Proceedings of EGM held on May 27, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Parmax Pharma Ltd held an Extra Ordinary General Meeting on May 27, 2026, which lasted 30 minutes with 15 members present. The EGM addressed five agenda items concerning director appointments. Two Ordinary Resolutions were proposed: appointment of Mr. Pradeep Ramniklal Gosalia and Ms. Salma Badrufin Thobhani as Non-Executive Directors. Three Special Resolutions were proposed: appointment of Mr. Ashish Atmaram Shah and Ms. Anjana Paresh Shah as Non-Executive Independent Directors, and re-appointment of Mr. Umang Alkesh Gosalia as Managing Director. Remote e-voting was available from May 24-26, 2026, and physical voting was also provided during the meeting. The actual voting outcomes will be disclosed separately along with the scrutinizer's report.
This EGM marks potential changes in the company's board composition and leadership continuity. The appointment of two new independent directors may strengthen corporate governance, while the re-appointment of the Managing Director ensures continuity in leadership. Actual impact on shareholders will be clearer once voting results are announced.